CSIMarket
 


Electrocore Inc   (NASDAQ: ECOR)
Other Ticker:  
 
 

ECOR's Revenue Growth by Quarter and Year

Electrocore Inc 's Revenue results by quarter and year




ECOR Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December 6.33 4.39 2.56 1.49
III Quarter September 6.49 4.51 1.98 1.49
II Quarter June 6.14 3.55 2.16 1.27
I Quarter March 5.44 2.78 1.90 1.20
FY   24.40 15.23 8.60 5.45



ECOR Revenue fourth quarter 2024 Y/Y Growth Comment
Electrocore Inc reported Revenue rise of 44.1% year on year in the fourth quarter 2024, to $ 6.33 millions, this is lower than Electrocore Inc 's recent average Revenue surge of 106.69%.

Looking into fourth quarter 2024 results within Medical Equipment & Supplies industry 47 other companies have achieved higher Revenue growth. While Electrocore Inc ' s Revenue jump of 44.1% ranks overall at the positon no. 688 in the fourth quarter 2024.




ECOR Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December 44.1 % 71.48 % 71.81 % 60.22 %
III Quarter September 43.9 % 127.78 % 32.89 % 37.96 %
II Quarter June 72.96 % 64.35 % 70.08 % 69.33 %
I Quarter March 95.68 % 46.32 % 58.33 % 64.38 %
FY   60.18 % 77.09 % 57.8 % 56.16 %

Financial Statements
Electrocore Inc 's fourth quarter 2024 Revenue $ 6.33 millions ECOR's Income Statement
Electrocore Inc 's fourth quarter 2023 Revenue $ 4.39 millions Quarterly ECOR's Income Statement


ECOR Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December -2.53 % -2.66 % 29.29 % 0 %
III Quarter September 5.7 % 27.04 % -8.33 % 17.32 %
II Quarter June 12.87 % 27.7 % 13.68 % 5.83 %
I Quarter March 23.92 % 8.59 % 27.52 % 29.03 %
FY (Year on Year)   60.18 % 77.09 % 57.8 % 56.16 %




Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #48
Healthcare Sector #154
Overall #688

Revenue Y/Y Growth Statistics
High Average Low
562.71 % 106.69 % 46.1 %
(Mar 31 2020)   (Mar 31 2021)
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #48
Healthcare Sector #154
Overall #688
Revenue Y/Y Growth Statistics
High Average Low
562.71 % 106.69 % 46.1 %
(Mar 31 2020)   (Mar 31 2021)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Electrocore Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
52.04 % 10.62 % -61.61 %
(Jun 30 2019)  


ECOR's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2024 Electrocore Inc disclosed fall in Revenue from the previous quarter by -2.53% to $ 6.33 millions, from $ 6.49 millions released in the previous quarter.

But that's not important issue, as Revenue frequently seem to dip in this quarter.

Within Medical Equipment & Supplies industry 127 other companies have achieved higher Revenue quarter on quarter growth. While Electrocore Inc 's Revenue growth quarter on quarter, overall rank is 2391.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #128
Healthcare Sector #411
Overall #2391
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #128
Healthcare Sector #411
Overall #2391
Revenue Q/Q Growth Statistics
High Average Low
52.04 % 10.62 % -61.61 %
(Jun 30 2019)  


ECOR's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2024 Electrocore Inc disclosed fall in Revenue from the previous quarter by -2.53% to $ 6.33 millions, from $ 6.49 millions released a quarter before.

It's not important problem, as Electrocore Inc 's Revenue frequently tend to plunge in the IV. QuarterMost analysts noted.

Within Medical Equipment & Supplies industry 127 other companies have achieved higher Revenue quarter on quarter growth. While Electrocore Inc 's Revenue growth quarter on quarter, overall rank is 2391.


Electrocore Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2024)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
Cumulative Revenue 12 Months Ending $ 24.40 $ 22.46 $ 20.48 $ 17.89 $ 15.23
Y / Y Revenue Growth (TTM) 60.23 % 67.61 % 88.43 % 88.84 % 77.21 %
Year on Year Revenue Growth Overall Ranking # 90 # 128 # 51 # 87 # 125
Seqeuential Revenue Change (TTM) 8.63 % 9.67 % 14.47 % 17.49 % 13.64 %
Seq. Revenue Growth (TTM) Overall Ranking # 688 # 434 # 349 # 635 # 635


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2024 period, Electrocore Inc 's cumulative twelve months Revenue were $ 24 millions, company would post below average annual Revenue growth of 13.64% year on year, if the fiscal year would end at Dec 31 2024.
A slow-down in the Electrocore Inc 's Revenue growth from the 6.49% growth in Sep 30 2024.

In the Healthcare sector 35 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 90, from total ranking in previous quarter at 128.

Revenue TTM Q/Q Growth Statistics
High Average Low
562.71 %
106.69 %
46.1 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 48
Healthcare Sector # 36
Overall # 90

Revenue TTM Y/Y Growth Statistics
High Average Low
562.71 %
106.69 %
46.1 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 48
Sector # 154
S&P 500 # 688
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2024 period, Electrocore Inc 's cumulative twelve months Revenue were $ 24 millions, company would post below average annual Revenue growth of 46.1% year on year, if the fiscal year would end at Dec 31 2024.
A slow-down in the Electrocore Inc 's Revenue growth from the 6.49% growth in Sep 30 2024.

In the Healthcare sector 35 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 90, from total ranking in previous quarter at 128.

Revenue TTM Q/Q Growth Statistics
High Average Low
562.71 %
106.69 %
46.1 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 48
Healthcare Sector # 36
Overall # 90

Revenue TTM Y/Y Growth Statistics
High Average Low
562.71 %
106.69 %
46.1 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 48
Sector # 154
S&P 500 # 688




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ECOR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ECOR's Competitors
Revenue Growth for Electrocore Inc 's Suppliers
Revenue Growth for ECOR's Customers

You may also want to know
ECOR's Annual Growth Rates ECOR's Profitability Ratios ECOR's Asset Turnover Ratio ECOR's Dividend Growth
ECOR's Roe ECOR's Valuation Ratios ECOR's Financial Strength Ratios ECOR's Dividend Payout Ratio
ECOR's Roa ECOR's Inventory Turnover Ratio ECOR's Growth Rates ECOR's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2024
Pluri Inc76.19%$ 76.190 millions
Protalix Biotherapeutics inc 73.74%$ 73.736 millions
Standard Biotools Inc 73.73%$ 73.726 millions
Predictive Oncology Inc 73.05%$ 73.047 millions
Silence Therapeutics Plc69.41%$ 69.406 millions
Genedx Holdings Corp 66.30%$ 66.298 millions
Sarepta Therapeutics Inc 65.94%$ 65.938 millions
Zai Lab Limited65.68%$ 65.684 millions
Eton Pharmaceuticals Inc 62.62%$ 62.617 millions
Stereotaxis Inc 61.50%$ 61.504 millions
Aprea Therapeutics Inc 61.34%$ 61.344 millions
Procept Biorobotics Corporation59.55%$ 59.553 millions
C4 Therapeutics Inc 58.75%$ 58.755 millions
Tandem Diabetes Care Inc 58.66%$ 58.660 millions
Sanara Medtech Inc 57.83%$ 57.832 millions
Cadre Holdings Inc 57.46%$ 57.456 millions
Natera inc 53.02%$ 53.023 millions
Mersana Therapeutics Inc 52.89%$ 52.892 millions
Jaguar Health Inc 52.57%$ 52.565 millions
Agios Pharmaceuticals Inc 51.06%$ 51.063 millions
Intra cellular Therapies Inc 50.81%$ 50.813 millions
Immutep Limited50.74%$ 50.739 millions
Cardiff Lexington Corporation50.65%$ 50.647 millions
Inspiremd Inc 50.64%$ 50.641 millions
Transmedics Group Inc 49.83%$ 49.831 millions
Vivos Therapeutics Inc 49.12%$ 49.122 millions
Profound Medical Corp 48.35%$ 48.354 millions
Kiniksa Pharmaceuticals International plc46.93%$ 46.934 millions
Evofem Biosciences Inc 46.81%$ 46.807 millions
Interpace Biosciences Inc 46.12%$ 46.117 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com